#biosimilars
#biosimilars

[ follow ]

Biopharmaceutical Patent Litigation: Regeneron's Defense Against Biosimilar Launches

Regeneron is actively defending its EYLEA patents against biosimilar manufacturers in court.

Design-Around Victory: Amgen's Self-Buffering Innovation Regeneron's Claims

The Federal Circuit affirmed Amgen's biosimilar, emphasizing its unique formulation and contrasting it with prior rulings against other manufacturers.

[ Load more ]

#biosimilars#biosimilars

Biopharmaceutical Patent Litigation: Regeneron's Defense Against Biosimilar Launches

Design-Around Victory: Amgen's Self-Buffering Innovation Regeneron's Claims

#biosimilars
#biosimilars